• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-08-03

  The referenced study reveals that MLKL polymerization at the lysosomal membrane triggers membrane permeabilization, leading to cathepsin release and programmed necroptotic cell death. These findings clarify a previously obscure mechanistic link, with direct implications for understanding regulated cell death and related disease processes.

• JZL184 (SKU B1958): Scenario-Driven Solutions for Assay Reli

  2026-08-03

  This article provides a practical, scenario-based guide to deploying JZL184 (SKU B1958) for robust endocannabinoid signaling research. It addresses common laboratory challenges—such as reproducibility, workflow optimization, and vendor selection—while grounding recommendations in quantitative data and peer-reviewed literature. The guide highlights how JZL184 from APExBIO advances analgesia, antinociception, and anxiolytic research by delivering validated results.

• Targeting Cdc42 to Mitigate Kidney Fibrosis: Insights from R

  2026-08-02

  This article reviews a recent study identifying Cdc42 as a direct molecular target for anti-fibrotic intervention in kidney disease, using the natural compound daphnepedunin A to disrupt pro-fibrotic signaling pathways. The findings offer new mechanistic understanding and highlight practical avenues for researchers investigating Cdc42-mediated pathways in fibrosis.

• MitMAB: Precision Tool for Dynamin-Dependent Endocytosis Stu

  2026-08-01

  MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide) empowers researchers to dissect the dynamin-mediated endocytic pathways in advanced organoid and stem cell models with robust specificity. Unlocking membrane trafficking mechanisms, this APExBIO research compound is central to innovative workflows, troubleshooting clarity, and next-generation cellular uptake studies.

• MPC-Driven Lactate Modulation Shapes Tumor Immunity via Hist

  2026-07-31

  This study reveals that mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer promotes lactate-driven histone lactylation in dendritic cells, impairing anti-tumor immunity and diminishing immunotherapy efficacy. The findings highlight metabolic-epigenetic crosstalk as a promising target for modulating the tumor microenvironment in cancer research.

• MitMAB: Precision Inhibition of Dynamin-Mediated Endocytosis

  2026-07-31

  MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide) is a potent dynamin GTPase activity inhibitor, enabling targeted studies of endocytosis and membrane trafficking. This dossier details its mechanism, evidence, and optimal use in organoid and membrane remodeling research.

• Doxycycline in Precision Vascular Research: Targeted Deliver

  2026-07-30

  Explore the multifaceted role of Doxycycline as a tetracycline antibiotic and metalloproteinase inhibitor in precision vascular research. This article uniquely examines cutting-edge nanoparticle delivery strategies and assay implications, offering new perspectives beyond conventional applications.

• Sulfaphenazole Restores Perfusion and Reduces Pressure Injur

  2026-07-30

  The reference study demonstrates that Sulfaphenazole, a selective CYP2C9 inhibitor, markedly reduces the severity of thermal and pressure-induced skin injuries in a murine model by rapidly restoring tissue perfusion and attenuating inflammation and fibrosis. These findings highlight a new application for Sulfaphenazole in vascular and wound healing research, with significant implications for modeling ischemia–reperfusion injury in preclinical settings.

• Podophyllotoxin: Deep Mechanistic Insights for Autophagy and

  2026-07-29

  Explore the unique role of Podophyllotoxin in autophagy, cell cycle arrest, and apoptosis induction with a focus on its applications in hepatocellular carcinoma research. This article offers advanced scientific context and actionable protocols, distinct from prior content.

• 1-myristoylglycerophosphocholine in Lipid Signaling and Fibr

  2026-07-29

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) is a pivotal tool for dissecting lipid signaling in smooth muscle and fibrosis models. This guide provides actionable workflows, troubleshooting strategies, and insight into protocol optimization based on the latest mechanistic research.

• Nigericin: Potassium/Hydrogen Ion Carrier for Precision Rese

  2026-07-28

  Nigericin’s unique potassium/hydrogen ion carrier activity enables precise modulation of intracellular pH and mitochondrial gradients, unlocking new avenues in cancer and antimicrobial research. This article details workflow enhancements, protocol optimization, and troubleshooting strategies, empowering scientists to harness Nigericin’s full experimental potential.

• Dutasteride in Prostate Cancer Research: Reliable Assay Outc

  2026-07-28

  This article addresses common challenges in prostate cancer and BPH research, focusing on experimental reproducibility and data reliability when using Dutasteride (SKU A1659). Scenario-driven Q&A blocks clarify best practices for inhibitor selection, assay optimization, and data interpretation, highlighting APExBIO’s Dutasteride as a validated, workflow-friendly reagent.

• EdU Imaging Kits (Cy5): Precision Cell Cycle S-Phase Quantif

  2026-07-27

  Explore how EdU Imaging Kits (Cy5) enable precise, high-sensitivity cell cycle S-phase DNA synthesis measurement. This article offers a deeper scientific perspective on assay choice, protocol optimization, and the impact of genomic regulation insights for advanced cell proliferation studies.

• Podophyllotoxin in Cancer Research: Protocols, Innovation &

  2026-07-27

  Podophyllotoxin stands out as a microtubule inhibitor enabling advanced cancer research, especially for multidrug-resistant models. This article dives into experimental workflows, recent mechanistic breakthroughs, and actionable troubleshooting tips leveraging APExBIO’s trusted reagent.

• Ca2+-Dependent Autophagy and Lysosomal Alkalinization in GBM

  2026-07-26

  This study demonstrates that NNC-55–0396 induces glioblastoma cell death through simultaneous activation and blockade of autophagy, mediated by ER Ca2+ mobilization and disrupted lysosomal acidification. These findings clarify how dysregulated calcium signaling and autophagy flux contribute to glioblastoma vulnerability, informing future research into targeted cancer therapies.

16210 records 1/1081 page Next 12345 下5页 Last page